Joyce Koh, MD
Gastroenterology · Bend, ORNPI 1144480484
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.8% of the total across 230 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Salix Pharmaceuticals, A Division Of Bausch Health US, LLC at 24.2% of the total. Reporting peaked in 2021 at $1,444 and has fallen 99.0% since, to $15 in 2024. Among gastroenterology clinicians in OR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 230 payments — averaging $17.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$981
- AbbVie$837
- Gilead$574
- Intercept Pharmaceuticals, Inc.$328
- Johnson & Johnson$324
- Takeda Pharmaceuticals U.S.A., Inc.$190
- plus $815 from 13 others
What the payments were for
- Consulting fees$341%
- Food & beverage$3,75693%
- Education$2576%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 76 | $981 |
| AbbVie(2 entities) | 40 | $837 |
| Gilead | 26 | $574 |
| Intercept Pharmaceuticals, Inc. | 11 | $328 |
| Johnson & Johnson | 16 | $324 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $190 |
| Bristol Myers Squibb | 17 | $184 |
| Nestle Healthcare Nutrition Inc. | 6 | $128 |
| Ironwood Pharmaceuticals, Inc | 7 | $105 |
| Cumberland Pharmaceuticals, Inc. | 5 | $92 |
| Biofire Diagnostics, LLC | 1 | $85 |
| Romark Laboratories, LC | 3 | $48 |
| Redhill Biopharma Inc. | 2 | $47 |
| Braintree Laboratories, Inc. | 3 | $45 |
| QOL Medical, LLC | 1 | $23 |
| Alfasigma USA, Inc. | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $15 |
| Merck | 1 | $13 |
| Daiichi Sankyo Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,048 in reported general payments places this provider in the 90th percentile of 220 gastroenterology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 14 | $4,928 |
| Omeprazole | 48 | $879 |
| Esomeprazole Magnesium | 30 | $878 |
| Pantoprazole Sodium | 26 | $644 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Bend
- Courtney WalkerBend$6K
- Richard BochnerBend$4K
- Meghan GilroyBend$4K
- Sandra HollowayBend$4K
- Jade EdwardsBend$2K
- Laurel HartwellBend$2K
- Matthew WeedBend$1K
- Donald LumPortland$320K
- Rebecca MatroPortland$154K
- Ian HolmesPortland$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.